Virginia Mason Medical Center, Seattle, Washington, USA.
University of Iowa, Iowa City, Iowa, USA.
Otolaryngol Head Neck Surg. 2023 Jun;168(6):1511-1520. doi: 10.1002/ohn.165. Epub 2023 Mar 19.
Evaluate health-related quality of life (HR-QOL) benefits with cochlear implantation (CI) in children with unilateral sensorineural hearing loss (USNHL) versus bilateral sensorineural hearing loss (BSNHL).
A cross-sectional survey of parents of children who underwent CI for USNHL and BSNHL.
Tertiary care academic centers.
The "Children with cochlear implants: parental perspectives" survey was administered. Parents rated responses on a 5-point Likert scale. Scores greater than 3.0 were considered favorable. Responses were recorded within 8 domains and groups were compared with respect to domain scores. Analysis of covariance models was used to compare groups while adjusting for age at implantation and duration of implant use.
There were 31 patients with USNHL and 27 patients with BSNHL. The average age of implantation in BSNHL patients was 1.9 and 6.7 years for USNHL. Parents of all children answered favorably in all domains. When adjusted for age at implantation and duration of implant use, parents of BSNHL children responded significantly more favorably only in 2 domains. When comparing patients with older age or prolonged duration of hearing loss in the USNHL cohort, there were favorable responses in all domains with no significant differences between groups.
There are HR-QOL benefits of CI in USNHL children; less pronounced favorable results were noted only in 2 domains when compared to BSNHL children. Benefits were noted with CI in USNHL children at an older age at implantation or prolonged duration of hearing loss. Therefore, these factors should not be absolute contraindications for CI in USNHL.
评估单侧感音神经性听力损失(USNHL)与双侧感音神经性听力损失(BSNHL)儿童行人工耳蜗植入(CI)后的健康相关生活质量(HR-QOL)获益。
一项针对 USNHL 和 BSNHL 行 CI 儿童家长的横断面调查。
三级学术医疗中心。
采用“植入人工耳蜗的儿童:家长观点”调查问卷进行调查。家长们对 5 点李克特量表的回答进行评分。评分大于 3.0 被认为是有利的。记录了 8 个领域内的回答,并根据域评分比较了组间的差异。采用协方差分析模型比较组间差异,同时调整植入年龄和植入使用时间的影响。
共有 31 例 USNHL 患儿和 27 例 BSNHL 患儿。BSNHL 患儿的平均植入年龄为 1.9 岁,USNHL 患儿为 6.7 岁。所有儿童的家长在所有领域的回答都很积极。调整植入年龄和植入使用时间后,BSNHL 患儿的家长仅在 2 个领域的回答明显更积极。在比较 USNHL 患儿中年龄较大或听力损失持续时间较长的患者时,所有领域均有积极的反应,且组间无显著差异。
USNHL 儿童行 CI 有 HR-QOL 获益;与 BSNHL 儿童相比,仅在 2 个领域注意到了不太明显的有利结果。在植入年龄较大或听力损失持续时间较长的 USNHL 儿童中,CI 也有获益。因此,这些因素不应成为 USNHL 儿童行 CI 的绝对禁忌证。